The newly added medicines include two for type 2 diabetes, Jentadueto and Jentadueto XR, and one for chronic obstructive ...

You did it to yourself.” This is one of the things that patients who are diagnosed with COPD often hear because of the stigma ...

The researchers noted that their results do not support the hypothesis that blocking vitamin K–dependent pathways worsens ...

Patients with COPD and coexisting OSAS have greater impairments in muscle quality and physical performance than those with isolated COPD.

Escalating to extrafine single-inhaler triple therapy significantly reduces exacerbations in patients with moderate to severe COPD.

Patients with COPD and heart failure treated with SGLT-2 inhibitors experienced higher rates of volume depletion and adverse renal events. Chronic obstructive pulmonary disease (COPD) reduces the ...

New long-acting muscarinic antagonist-long-acting beta agonist users had a decreased risk for a first moderate/severe COPD ...

Chronic obstructive pulmonary disease, or COPD, is the 5th-leading cause of death in the United States and the cause of more ...

Quitting smoking and avoiding vaping may be crucial steps in managing COPD, as these habits expose your lungs to irritants that cause further damage. Quitting may slow the disease’s progression and ...

Asthma and COPD patients in the UK are set to receive faster, community-based care under a £10 million NHS initiative, ...

COPD affects at least 4.5% of those 18-49 years old, according to an analysis of U.S. cohorts. The early COPD group was more likely to be hospitalized or die from chronic respiratory disease, to ...

Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Cl ...